At Janssen, what matters most is a healthy outcome for each patient. Janssen is committed to providing safe and effective medicines as well as the services and support that contribute to healthy outcomes. This calls for the best science, the most creative minds and an openness to collaborate with researchers, governments and patient organizations at every stage – from early discovery to market access and patient education. Now the fastest growing top 10 pharmaceutical company globally, Janssen is focusing their unique model of innovation on some of the most devastating diseases and the most complex medical challenges of our time, across five therapeutic areas. Their search for transformational solutions lends a special urgency to their work. Janssen challenges itself every day to replenish its pipeline and reduce the time it takes to bring innovative solutions to the patients who need them. After all, their responsibility as a Credo-driven, Johnson & Johnson company is to put people first. Janssen collaborates with the world for the health of everyone in it.